Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 10 May 1985:
Vol. 228. no. 4700, pp. 669 - 677
DOI: 10.1126/science.3992240

Articles

Science, Vol 228, Issue 4700, 669-677
Copyright © 1985 by American Association for the Advancement of Science


articles

Activated proto-onc genes: sufficient or necessary for cancer?

PH Duesberg

Proto-onc genes are normal cellular genes that are related to the transforming (onc) genes of retroviruses. Because of this relationship these genes are now widely believed to be potential cancer genes. In some tumors, proto-onc genes are mutated or expressed more than in normal cells. Under these conditions, proto-onc genes are hypothesized to be active cancer genes in one of two possible ways: The one gene-one cancer hypothesis suggests that one activated proto-onc gene is sufficient to cause cancer. The multigene-one cancer hypothesis suggests that an activated proto-onc gene is a necessary but not a sufficient cause of cancer. However, mutated or transcriptionally activated proto-onc genes are not consistently associated with the tumors in which they are occasionally found and do not transform primary cells. Further, no set of an activated proto-onc gene and a complementary cancer gene with transforming function has yet been isolated from a tumor. Thus, there is still no proof that activated proto-onc genes are sufficient or even necessary to cause cancer.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Heparin/Heparan Sulfate Interacting Protein Gene Expression Is Up-regulated in Human Colorectal Carcinoma and Correlated with Differentiation Status and Metastasis.
Y. Wang, D. Cheong, S. Chan, and S. C. Hooi (1999)
Cancer Res. 59, 2989-2994
   Abstract »    Full Text »    PDF »
Human retinoblastoma susceptibility gene: cloning, identification, and sequence.
W. Lee, R Bookstein, F Hong, L. Young, J. Shew, and E. Lee (1987)
Science 235, 1394-1399
   Abstract »    PDF »
Differentiation-linked leukemogenesis in lymphocytes.
M. Greaves (1986)
Science 234, 697-704
   Abstract »    PDF »
A turning point in cancer research: sequencing the human genome.
R Dulbecco (1986)
Science 231, 1055-1056
   PDF »
Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation.
J Yokota, Y Tsunetsugu-Yokota, H Battifora, C Le Fevre, and M. Cline (1986)
Science 231, 261-265
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)